AI-generated passwords are long, complex, and impossible to memorize. They're also built on repetitive character sequences that hackers can guess in seconds. I review privacy tools like hardware ...

Unwise design choices from a specialty password manager allowed any malicious website to obtain complete, persistent access to customers' vaults. "Passportal" is a credential management product from N ...

Hosted by Rosie GuerinCaira Blackwell and Christine Cyr Clisset If you feel burned out by endless passwords, security alerts and authentication codes, you’re not alone. It can feel as if the rules for ...

You’ll sacrifice some nice-to-have features by going with a free password manager, but Bitwarden doesn’t skimp on the ones that matter. A high-quality free ...

Apple today announced that the Passwords app can now automatically update weak and compromised passwords using Apple Intelligence and Safari to take action on a user's behalf. The feature builds on ...

If you’ve been hearing a lot more about passkeys recently, there’s good reason for it. After becoming more widely available in 2022, passkeys have surged in popularity, driven by ease of use and ...

Apps from Apple, Google and others can assist in making your online accounts more secure, even as new ways of logging in continue to take off. By J. D. Biersdorfer J.D. Biersdorfer writes about how to ...

WTF?! Microsoft advertises its password manager as having robust encryption on par with well-regarded third-party options. However, security researchers have discovered that the browser effectively ...

A Norwegian researcher has identified an issue with Microsoft Edge’s Password Manager that could be a serious concern for businesses. Tom Jøran Sønstebyseter Rønning found that passwords are being ...

Have you ever had Apple Passwords generate a new password that didn’t end up being saved correctly? Sometimes a website crashes at the wrong moment, or uses protocols that don’t exactly play nice with ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...